Evidence map›Paper›PMID 39182157›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.

Iris R Montez de Sousa, Marjolein Bonthuis, Anneke Kramer, Flor Angel Ordoñez, Francisco de la Cerda Ojeda, Helena Rydell, Jaakko Helve, Jaap W Groothoff, Kristine Hommel, Lukas Buchwinkler and 11 more

Abstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Iris R Montez de SousaESPN/ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Marjolein BonthuisESPN/ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-1719-940X
Anneke KramerAmsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands.
Flor Angel OrdoñezPediatric Nephrology Unit, Department of Pediatrics, Hospital Universitario Central de Asturias, Oviedo, Spain.
Francisco de la Cerda OjedaVirgen del Rocio Hospital, Sevilla, Spain.
Helena RydellDepartment of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Sweden.
Jaakko HelveFinnish Registry for Kidney Diseases, Helsinki, Finland.
Jaap W GroothoffDepartment of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kristine HommelDepartment of Medicine, Holbaek Hospital, Holbaek, Denmark.
Lukas BuchwinklerAustrian Dialysis and Transplantation Registry, Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
Mårten SegelmarkDepartment of Clinical Sciences Lund, Nephrology, Lund University, Skane University Hospital, Lund, Sweden.
Mustafa AriciDepartment of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
Runolfur PalssonDivision of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Samira BellScottish Renal Registry, Meridian Court, Glasgow, UK.
Sara Trujillo-AlemánHealth Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Canary Islands, Spain.
Sevcan A BakkalogluDepartment of Pediatric Nephrology, Gazi University, Ankara, Türkiye.
Søren S SørensenDepartment of Nephrology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Anna VilaDepartment of Nephrology, University Hospital Germans Trias I Pujol (HGiTP), Badalona (Barcelona), Catalonia, Spain.
Alberto OrtizDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.
Vianda S StelAmsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands.
Kitty J JagerAmsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands.

Funding

European Renal AssociationEuropean Society of Paediatric Nephrology
6 · The paper itself

Abstract

backgroundYoung adults starting kidney replacement therapy (KRT) during childhood and reaching their 18th birthday (i.e. adult survivors of childhood KRT) form a challenging population of interest to nephrologists treating adults, as during this period there will be a transition to adult renal centres. Nonetheless, few studies have focused on the epidemiology of KRT in this group. We aimed to provide an update on these patients' characteristics, treatment history, and graft and patient survival, to report their 5-year prognosis and expected remaining lifetime.

methodsData on KRT patients reaching their 18th birthday in 2008-19 were collected from 21 European countries/regions providing individual patient data to the European Renal Association (ERA) Registry. Patient characteristics and treatment trajectories were examined before and after turning 18 years old. Kaplan-Meier and Cox proportional hazards regression were used for patient and graft survival analyses.

resultsIn total, 2944 patients were included. The proportion of adult survivors initiating KRT at a very young age (0-4 years) and undergoing pre-emptive kidney transplantation increased. Unadjusted 5-year patient survival was 96.9% [95% confidence interval (CI) 96.2-97.5]. Dialysis patients had a higher risk of death than kidney transplant recipients [adjusted hazard ratio 5.44 (95% CI 3.34-8.86)]. Between ages 18 and 23 years, about 21% of the adult survivors lost their kidney transplant and 34% of the dialysis patients continued this treatment. Compared with the general population, life expectancy for 18-year-old kidney transplant and dialysis patients was 17 and 40 years shorter, respectively.

conclusionLife expectancy of 18-year-old kidney transplant recipients was lower compared with the general population, yet having a functioning kidney graft at age 18 years resulted in better outcomes than being on dialysis. Nevertheless, between ages 18 and 23 years, about one-fifth of the kidney grafts failed and one-third of the patients remained on dialysis.

Indexed as

Kidney Failure, ChronicKidney TransplantationRegistriesRenal Replacement TherapyAdolescentAdultChildChild, PreschoolEuropeFemaleFollow-Up StudiesGraft SurvivalHumansInfantInfant, NewbornMalekidney replacement therapykidney transplantationpaediatric nephrologytransitionyoung adults

Identifiers

PMID39182157
PMCPMC11997785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.